364 related articles for article (PubMed ID: 34578365)
1. Rhinovirus Inhibitors: Including a New Target, the Viral RNA.
Real-Hohn A; Blaas D
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578365
[TBL] [Abstract][Full Text] [Related]
2. Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
Murer L; Petkidis A; Vallet T; Vignuzzi M; Greber UF
J Virol; 2022 Jan; 96(2):e0106021. PubMed ID: 34705560
[TBL] [Abstract][Full Text] [Related]
3. Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules.
Shih SR; Chen SJ; Hakimelahi GH; Liu HJ; Tseng CT; Shia KS
Med Res Rev; 2004 Jul; 24(4):449-74. PubMed ID: 15170592
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of the Quadruplex-Forming G-Rich Sequences in the Rhinovirus Genome Inhibits Uncoating-Role of Na
Real-Hohn A; Groznica M; Kontaxis G; Zhu R; Chaves OA; Vazquez L; Hinterdorfer P; Kowalski H; Blaas D
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112983
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.
Hrebík D; Füzik T; Gondová M; Šmerdová L; Adamopoulos A; Šedo O; Zdráhal Z; Plevka P
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33947819
[TBL] [Abstract][Full Text] [Related]
7. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.
Rollinger JM; Schmidtke M
Med Res Rev; 2011 Jan; 31(1):42-92. PubMed ID: 19714577
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy for enteroviruses and rhinoviruses.
Rotbart HA
Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
[TBL] [Abstract][Full Text] [Related]
9. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ
Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.
Li C; Wang H; Shih SR; Chen TC; Li ML
Curr Med Chem; 2007; 14(8):847-56. PubMed ID: 17430140
[TBL] [Abstract][Full Text] [Related]
11. Catching Common Cold Virus with a Net: Pyridostatin Forms Filaments in Tris Buffer That Trap Viruses-A Novel Antiviral Strategy?
Real-Hohn A; Zhu R; Ganjian H; Ibrahim N; Hinterdorfer P; Kowalski H; Blaas D
Viruses; 2020 Jul; 12(7):. PubMed ID: 32635420
[TBL] [Abstract][Full Text] [Related]
12. Rhinovirus chemotherapy.
Patick AK
Antiviral Res; 2006 Sep; 71(2-3):391-6. PubMed ID: 16675037
[TBL] [Abstract][Full Text] [Related]
13. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
14. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
Egorova A; Ekins S; Schmidtke M; Makarov V
Eur J Med Chem; 2019 Sep; 178():606-622. PubMed ID: 31226653
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistance.
Richter M; Döring K; Blaas D; Riabova O; Khrenova M; Kazakova E; Egorova A; Makarov V; Schmidtke M
Antiviral Res; 2024 Feb; 222():105810. PubMed ID: 38244889
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in rhinovirus therapeutics.
Charles CH; Yelmene M; Luo GX
Curr Drug Targets Infect Disord; 2004 Dec; 4(4):331-7. PubMed ID: 15578974
[TBL] [Abstract][Full Text] [Related]
17. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.
Abdelnabi R; Geraets JA; Ma Y; Mirabelli C; Flatt JW; Domanska A; Delang L; Jochmans D; Kumar TA; Jayaprakash V; Sinha BN; Leyssen P; Butcher SJ; Neyts J
PLoS Biol; 2019 Jun; 17(6):e3000281. PubMed ID: 31185007
[TBL] [Abstract][Full Text] [Related]
18. Characterization of G-Quadruplexes in Enterovirus A71 Genome and Their Interaction with G-Quadruplex Ligands.
Lv L; Zhang L
Microbiol Spectr; 2022 Jun; 10(3):e0046022. PubMed ID: 35446122
[TBL] [Abstract][Full Text] [Related]
19. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating.
Asare E; Mugavero J; Jiang P; Wimmer E; Paul AV
J Virol; 2016 Jul; 90(14):6174-6186. PubMed ID: 27076638
[TBL] [Abstract][Full Text] [Related]
20. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
